Replies to post #88547 on Anavex Life Sciences Corp (AVXL)

[gburgin]

So why even do a pivotal trial for AD? Just go after Rhett's and keep looking for a patentable 2-73 combo for AD. If there is no good AD alternative then 2-73 off label use should spread like wildfire. Question is whether significant and successful off label use for AD would bring in the generic makers. If so then do you get the 5 year exclusion for AD if it's only approved for Rhett's?